Innovation Pharmaceuticals Financials
| IPIX Stock | USD 0.0003 0.0001 25.00% |
Innovation |
Understanding current and past Innovation Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Innovation Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Innovation Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Innovation Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Innovation Pharmaceuticals. Check Innovation Pharmaceuticals' Beneish M Score to see the likelihood of Innovation Pharmaceuticals' management manipulating its earnings.
Innovation Pharmaceuticals Stock Summary
Innovation Pharmaceuticals competes with Cytodyn. Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. Innovation Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US45782D1000 |
| Business Address | 301 Edgewater Place, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.ipharminc.com |
| Phone | 978 921 4125 |
| Currency | USD - US Dollar |
Innovation Pharmaceuticals Key Financial Ratios
Innovation Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Innovation Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Innovation Pharmaceuticals over time and compare it to other companies across industries.| Return On Equity | -1.09 | |||
| Return On Asset | -0.32 | |||
| Beta | 0.18 | |||
| Z Score | -7.0 |
Innovation Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Innovation Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Innovation Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovation Pharmaceuticals competition to find correlations between indicators driving Innovation Pharmaceuticals's intrinsic value. More Info.Innovation Pharmaceuticals is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovation Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovation Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Innovation Pharmaceuticals Systematic Risk
Innovation Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Innovation Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Innovation Pharmaceuticals correlated with the market. If Beta is less than 0 Innovation Pharmaceuticals generally moves in the opposite direction as compared to the market. If Innovation Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Innovation Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Innovation Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Innovation Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Innovation Pharmaceuticals December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Innovation Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innovation Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innovation Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Innovation Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innovation Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 53.7 | |||
| Information Ratio | 0.2495 | |||
| Maximum Drawdown | 286.67 | |||
| Value At Risk | (60.00) | |||
| Potential Upside | 100.0 |
Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.